Home > Publications database > GABARAP interacts with EGFR — supporting the unique role of this hAtg8 protein during receptor trafficking > print

001     1030471
005     20250203133201.0
024 7 _ |a 10.1002/1873-3468.14997
|2 doi
024 7 _ |a 0014-5793
|2 ISSN
024 7 _ |a 1873-3468
|2 ISSN
024 7 _ |a 10.34734/FZJ-2024-05317
|2 datacite_doi
024 7 _ |a 39160442
|2 pmid
024 7 _ |a WOS:001285593800001
|2 WOS
037 _ _ |a FZJ-2024-05317
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Üffing, Alina
|0 P:(DE-Juel1)181095
|b 0
245 _ _ |a GABARAP interacts with EGFR — supporting the unique role of this hAtg8 protein during receptor trafficking
260 _ _ |a Chichester
|c 2024
|b Wiley
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1734176659_20063
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a The human Atg8 family member GABARAP is involved in numerous autophagy-related and -unrelated processes. We recently observed that specifically the deficiency of GABARAP enhances epidermal growth factor receptor (EGFR) degradation upon ligand stimulation. Here, we report on two putative LC3-interacting regions (LIRs) within EGFR, the first of which (LIR1) is selected as a GABARAP binding site in silico. Indeed, in vitro interaction studies reveal preferential binding of LIR1 to GABARAP and GABARAPL1. Our X-ray data demonstrate interaction of core LIR1 residues FLPV with both hydrophobic pockets of GABARAP suggesting canonical binding. Although LIR1 occupies the LIR docking site, GABARAP Y49 and L50 appear dispensable in this case. Our data support the hypothesis that GABARAP affects the fate of EGFR at least in part through direct binding.
536 _ _ |a 5241 - Molecular Information Processing in Cellular Systems (POF4-524)
|0 G:(DE-HGF)POF4-5241
|c POF4-524
|f POF IV
|x 0
536 _ _ |a SFB 1208 B02 - Spezifische Rollen von Atg8s im Vesikeltransport (B02) (289554527)
|0 G:(GEPRIS)289554527
|c 289554527
|x 1
588 _ _ |a Dataset connected to CrossRef, Journals: juser.fz-juelich.de
700 1 _ |a Weiergräber, Oliver H.
|0 P:(DE-Juel1)131988
|b 1
|e Corresponding author
700 1 _ |a Schwarten, Melanie
|0 P:(DE-Juel1)132019
|b 2
700 1 _ |a Hoffmann, Silke
|0 P:(DE-Juel1)132003
|b 3
|e Corresponding author
700 1 _ |a Willbold, Dieter
|0 P:(DE-Juel1)132029
|b 4
773 _ _ |a 10.1002/1873-3468.14997
|g p. 1873-3468.14997
|0 PERI:(DE-600)1460391-3
|n x
|p online ahead of print
|t FEBS letters
|v x
|y 2024
|x 0014-5793
856 4 _ |y OpenAccess
|u https://juser.fz-juelich.de/record/1030471/files/FEBS%20Letters%20-%202024%20-%20%C3%9Cffing%20-%20GABARAP%20interacts%20with%20EGFR%20supporting%20the%20unique%20role%20of%20this%20hAtg8%20protein%20during.pdf
856 4 _ |y OpenAccess
|u https://juser.fz-juelich.de/record/1030471/files/Ueffing_et_al_GABARAP%20interacts%20with%20EGFR_FEBS%20Letters.pdf
856 4 _ |y OpenAccess
|x icon
|u https://juser.fz-juelich.de/record/1030471/files/Ueffing_et_al_GABARAP%20interacts%20with%20EGFR_FEBS%20Letters.gif?subformat=icon
856 4 _ |y OpenAccess
|x icon-1440
|u https://juser.fz-juelich.de/record/1030471/files/Ueffing_et_al_GABARAP%20interacts%20with%20EGFR_FEBS%20Letters.jpg?subformat=icon-1440
856 4 _ |y OpenAccess
|x icon-180
|u https://juser.fz-juelich.de/record/1030471/files/Ueffing_et_al_GABARAP%20interacts%20with%20EGFR_FEBS%20Letters.jpg?subformat=icon-180
856 4 _ |y OpenAccess
|x icon-640
|u https://juser.fz-juelich.de/record/1030471/files/Ueffing_et_al_GABARAP%20interacts%20with%20EGFR_FEBS%20Letters.jpg?subformat=icon-640
909 C O |o oai:juser.fz-juelich.de:1030471
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 0
|6 P:(DE-Juel1)181095
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 1
|6 P:(DE-Juel1)131988
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 2
|6 P:(DE-Juel1)132019
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 3
|6 P:(DE-Juel1)132003
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 4
|6 P:(DE-Juel1)132029
913 1 _ |a DE-HGF
|b Key Technologies
|l Natural, Artificial and Cognitive Information Processing
|1 G:(DE-HGF)POF4-520
|0 G:(DE-HGF)POF4-524
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-500
|4 G:(DE-HGF)POF
|v Molecular and Cellular Information Processing
|9 G:(DE-HGF)POF4-5241
|x 0
914 1 _ |y 2024
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-08-23
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2023-08-23
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2023-08-23
|w ger
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-08-23
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2024-12-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2024-12-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-19
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b FEBS LETT : 2022
|d 2024-12-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2024-12-19
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2024-12-19
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2024-12-19
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)IBI-7-20200312
|k IBI-7
|l Strukturbiochemie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)IBI-7-20200312
980 1 _ |a FullTexts

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21